Morgan Stanley’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.3M | Buy |
|
|||||
|
2025
Q1 | $19.1M | Buy |
|
|||||
|
2024
Q4 | $18.3M | Sell |
|
|||||
|
2024
Q3 | $18.7M | Buy |
|
|||||
|
2024
Q2 | $18.2M | Buy |
|
|||||
|
2024
Q1 | $14.7M | Sell |
|
|||||
|
2023
Q4 | $32.7M | Buy |
|
|||||
|
2023
Q3 | $4.13M | Sell |
|
|||||
|
2023
Q2 | $7.45M | Sell |
|
|||||
|
2023
Q1 | $8.32M | Buy |
|
|||||
|
2022
Q4 | $8.52M | Buy |
|
|||||
|
2022
Q3 | $9.68M | Sell |
|
|||||
|
2022
Q2 | $7.35M | Buy |
|
|||||
|
2022
Q1 | $9.1M | Sell |
|
|||||
|
2021
Q4 | $14M | Buy |
|
|||||
|
2021
Q3 | $15.8M | Buy |
|